Amgen (AMGN) Tops Q1 EPS by 35c, Offers Guidance
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $355.39 +1.13%
EPS Growth %: -7.1%
Financial Fact:
Provision for income taxes: 401M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -7.1%
Financial Fact:
Provision for income taxes: 401M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q1 EPS of $5.15, $0.35 better than the analyst estimate of $4.80. Revenue for the quarter came in at $8.62 billion versus the consensus estimate of $8.59 billion.
GUIDANCE:
Amgen sees FY2026 EPS of $21.70-$23.10, versus the consensus of $22.30. Amgen sees FY2026 revenue of $37.1-38.5 billion, versus the consensus of $37.79 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Iran Attacks Ship In Strait Of Hormuz, US Officials Say - WSJ
- NextNav sets June 26 deadline for public warrant exercise
- Bumble Dating App Explores Sale, Sources Say - Reuters
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
